Looking to clarify its expectations on manufacturer responses following inspections, the FDA earlier this year unveiled, for ...
The US Food and Drug Administration (FDA) on Thursday finalized its guidance on the use of alternative tools for conducting preapproval inspections (PAI) or prelicense inspections (PLIs) in lieu of ...
Drug manufacturers looking to avoid Form 483s take note: the US Food and Drug Administration (FDA) has recently tweaked its compliance guide on pre-approval inspections, which according to one ...
In response to travel restrictions imposed during the COVID-19 pandemic, the U.S. Food and Drug Administration (“FDA”) began conducting remote regulatory assessments (“RRAs”) of medical products ...
Guide highlights key compliance scenarios—from FDA actions to global expansion—where consulting is essential. IRVINE, CA, UNITED STATES, April 1, 2026 ...
On January 21, the US Food and Drug Administration (FDA) issued a draft guidance clarifying the agency’s authority to access and copy records related to cosmetic products under the Modernization of ...
IRVINE, CA, UNITED STATES, April 1, 2026 / EINPresswire.com / — Qalitex Laboratories, an ISO 17025-accredited analytical testing laboratory serving supplement and pharmaceutical brands across North ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results